Ads
related to: johnson and johnson medical devices
Search results
Johnson & Johnson's Dividend Analysis
Guru Focus· 4 days agoJohnson & Johnson (JNJ, Financial) recently announced a dividend of $1.24 per share, payable on 2024-06-04, with the ex-dividend date set for 2024-05-20 ...
DD Stock Separation Plan: What to Know as DuPont Splits Into 3 Companies
InvestorPlace· 10 hours agoIndeed, DuPont will fracture its electronics and water sectors, leaving the third company more...
Smart Money Is Betting Big In JNJ Options - Johnson & Johnson (NYSE:JNJ)
Benzinga· 2 days agoThree divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug
Houston storm leaves vulnerable residents in the dark
FOX 26 Houston· 5 days agoIn the aftermath of the recent storm that ravaged parts of Houston, hundreds of thousands have found...
Factbox-Some of the biggest splits in Corporate America
Reuters via Yahoo Finance· 11 hours agoLabcorp says it will 2022 ... new company is called Warner Bros Discovery. Johnson & Johnson says it...
U.S. Food and Drug Administration (FDA) Extends its Memorandum of Understanding
Digital Journal· 4 days agoWe continue to work with those paving the way toward safe and reliable medtech. To date, Medcrypt has raised more than $36 million in funding with participation from
DuPont to split into three companies as CEO Breen steps back | Honolulu Star-Advertiser
Honolulu Star-Advertiser· 19 hours agoThe announcement follows a parade of corporate icons such as Johnson & Johnson, United Technologies,...
DuPont is latest industrial behemoth to split into multiple public companies
Morningstar· 1 day agoDuPont de Nemours Inc. said late Wednesday it will separate itself into three standalone, publicly traded companies within the coming months, one keeping the focus on industrial materials while ...
Biosense Webster Presents Late-Breaking Data from admIRE Clinical Trial at the Heart Rhythm Society...
FOX 4 Kansas City· 6 days agoBiosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech, announced late-breaking ...
Critics Say FDA's Use of Surrogate Markers Falling Short
Medscape· 7 days agoAs the FDA's use of surrogate endpoints in the drug approval process is increasing, researchers are...